menu search

3 warren buffett stocks to see skyrocketing ai growth

AI's potential in business operations isn't confined to tech giants; traditional industries are also poised to benefit. AI isn't just about user-facin...

September 24, 2023, 7:21 am

Is this the best stock to buy right now for less than $100 a share?

Crocs' brand has proved to be remarkably strong in consumer demand. With margins better than Nike, C...

September 24, 2023, 7:01 am

Crowdstrike stock rockets up 71%: 2 brilliant reasons to (still) buy

Moats, expanding relationships, printing cash....

September 24, 2023, 6:33 am

Coterra energy: an undervalued permian play

Coterra Energy presents a strong value relative to its peers when compared to its operating cash flows. Coterra is less leveraged relative to peers ex...

September 24, 2023, 4:33 am

Chase business loans: 2023 review

Chase may offer you a small-business loan with competitive rates and terms. In order to apply, you’ll need to connect with a Chase business loan spe...

September 24, 2023, 3:29 am

Blackrock: appealing again

Blackrock has reported impressive asset inflows, driven by bond-like products, despite market volatilit...

September 24, 2023, 3:23 am

Better gene editing stock: intellia therapeutics vs. rocket pharmaceuticals

rocket Pharmaceuticals has two programs approaching commercialization. By contrast, Intellia's candidat...

September 23, 2023, 9:45 am

5 best cefs this month for 9% yield (september 2023)

For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promises high distributions an...

September 23, 2023, 9:00 am

Missed out on nvidia's skyrocketing trillion-dollar ai run? here's my best ai chip stock to buy now and hold forever.

AI stocks are creating a buzz in 2023, giving Nvidia a lofty trillion-dollar market cap. NXP Semiconductors, though not commonly viewed as an AI giant...

September 23, 2023, 7:41 am

1 rock-solid warren buffett artificial intelligence (ai) dividend stock to buy and hold (hint: it's not apple)

Despite macroeconomic headwinds, Microsoft remains resilient, generating enviable growth. It also boasts a fortress-like balance sheet with plenty of ...

September 23, 2023, 6:35 am

U.s. ipo weekly recap: instacart and klaviyo ipos debut with mixed trading

The IPO market's tech unicorn drought ended this past week, with grocery delivery platform Instacart an...

September 23, 2023, 2:30 am

Uber eats to accept snap benefits for grocery deliveries in 2024

Uber Eats will soon accept Supplemental Nutrition Assistance Program benefits beginning in 2024 for groc...

September 22, 2023, 10:10 pm

Bdc weekly review: underperformers keep merging

We take a look at the action in business development companies through the third week of September and highlight some of the key themes we are watchin...

September 22, 2023, 9:50 pm

: u.s. stocks fall for 4th day, capping off worst week for s&p 500, nasdaq since march

U.S. stocks capped off a rocky week by finishing lower on Friday after erasing their gains from earlier...

September 22, 2023, 8:04 pm

Avecpay joins forces with rocketfuel to bring crypto payments to latin america

Tegucigalpa, Honduras, Sept. 22, 2023 (GLOBE NEWSWIRE) — rocketFuel, Inc. (OTCQB: RKFL) (“...

September 22, 2023, 7:05 pm

Igd: time to divest this financials heavy equity cef

Voya Global Equity Dividend and Premium Opportunity Fund is an equity closed-end fund with a 9.6% dividend yield. The fund has failed to produce meani...

September 22, 2023, 4:18 pm

Why coeur mining stock soared today

RBC Capital upgraded Coeur Mining shares to outperform this morning, reiterating its $4 per-share price target. The analyst was encouraged after a rec...

September 22, 2023, 3:58 pm

Cerro de pasco resources to raise up to c$2m in private placement financing

Cerro de Pasco Resources (CSE:CDPR, OTC:GPPRF) (CDPR) has announced that it intends to complete a non-brokered private placement offering of up to 20...

September 22, 2023, 3:37 pm

Protagonist therapeutics: there are reasons behind johnson & johnson's optimism

Protagonist Therapeutics, Inc.'s oral IL-23 drug for psoriasis, JNJ-2113, must show non-inferior efficacy to Johnson & Johnson's injectable Tremfya be...

September 22, 2023, 3:35 pm

Dear potential birk stock investors, mark your calendars for an october birkenstock ipo

Following a long drought in high-profile initial public offerings (IPOs), sandal maker Birkenstock is allegedly poised to help enliven p...

September 22, 2023, 3:25 pm


Search within

Pages Search Results: